(VIANEWS) – Shares of Castle Biosciences (NASDAQ Composite: CSTL) jumped by a staggering 20.33% in 7 days from $40.98 to $49.31 at 11:05 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ Composite is dropping 0% to $15,993.71, following the last session’s upward trend.
Castle Biosciences’s last close was $41.35, 61.6% under its 52-week high of $107.69.
Today’s last reported volume for Castle Biosciences is 307538 which is 63.97% above its average volume of 187550.
Castle Biosciences’s Sales
Castle Biosciences’s sales growth is 53.2% for the current quarter and 39.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 73.9% and a negative 69.6%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.62%, a negative 2.00%, and a positive 3.09%, respectively.
Castle Biosciences’s highest amplitude of average volatility was 2.43% (last week), 3.42% (last month), and 3.09% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Castle Biosciences’s stock is considered to be overbought (>=80).
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $49.31 at 11:05 EST, way under its 52-week high of $107.69 and way above its 52-week low of $43.37.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way below its 50-day moving average of $63.83 and way below its 200-day moving average of $67.01.
More news about Castle Biosciences (CSTL).